BRAINSTORM Legal Friday, November 20, 2026 +0.20 Positive

Brainstorm settles specific derivative litigation

Brainstorm Cell Therapeutics Inc. filed notice regarding a proposed settlement of a stockholder derivative action and the dismissal of a separate Section 220 inspection demand in New York federal court.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed